/

Xencor

Develops engineered antibody therapeutics for cancer and autoimmune diseases.

BiotechnologyPharmaceuticals xencor.com ↗

Company facts

Founded: 1997
Employees: 260
Headquarters: United States
Type: Public
Listed: NASDAQ: XNCR